These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 1889176)

  • 1. Antibiotic susceptibility profile of Xanthomonas maltophilia. In vitro activity of beta-lactam/beta-lactamase inhibitor combinations.
    García-Rodríguez JA; García Sánchez JE; García García MI; García Sánchez E; Muñoz Bellido JL
    Diagn Microbiol Infect Dis; 1991; 14(3):239-43. PubMed ID: 1889176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activities of beta-lactam-beta-lactamase inhibitor combinations against Stenotrophomonas maltophilia: correlation between methods for testing inhibitory activity, time-kill curves, and bactericidal activity.
    Muñoz Bellido JL; Muñoz Criado S; García García I; Alonso Manzanares MA; Gutiérrez Zufiaurre MN; García-Rodríguez JA
    Antimicrob Agents Chemother; 1997 Dec; 41(12):2612-5. PubMed ID: 9420028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of antimicrobial activity of aztreonam/clavulanic acid (2:1) against Xanthomonas maltophilia.
    García-Rodríguez JA; García Sánchez JE; Muñoz Bellido JL; García García MI; García Sánchez E
    J Antimicrob Chemother; 1991 Apr; 27(4):552-4. PubMed ID: 1856134
    [No Abstract]   [Full Text] [Related]  

  • 4. In-vitro susceptibility of Xanthomonas maltophilia to aztreonam and clavulanic acid as a test for the presumptive identification of the species.
    Townsend R; Winstanley TG; Spencer RC
    J Hosp Infect; 1991 Aug; 18(4):324-5. PubMed ID: 1682373
    [No Abstract]   [Full Text] [Related]  

  • 5. Susceptibility of 100 strains of Stenotrophomonas maltophilia to three beta-lactams and five beta-lactam-beta-lactamase inhibitor combinations.
    Lecso-Bornet M; Bergogne-Bérézin E
    J Antimicrob Chemother; 1997 Nov; 40(5):717-20. PubMed ID: 9421322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aztreonam-clavulanic acid synergy does not mean extended-spectrum beta-lactamase in Stenotrophomonas maltophilia.
    Muñoz Bellido JL; García-Rodriguez JA
    J Antimicrob Chemother; 1998 Apr; 41(4):493-4. PubMed ID: 9598782
    [No Abstract]   [Full Text] [Related]  

  • 7. Stenotrophomonas maltophilia: emergence of multidrug-resistant strains during therapy and in an in vitro pharmacodynamic chamber model.
    Garrison MW; Anderson DE; Campbell DM; Carroll KC; Malone CL; Anderson JD; Hollis RJ; Pfaller MA
    Antimicrob Agents Chemother; 1996 Dec; 40(12):2859-64. PubMed ID: 9124855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative activity of ticarcillin-clavulanic acid and various beta-lactams against Pseudomonas maltophilia].
    Monteil H; Jehl F
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):805-8. PubMed ID: 3309818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro susceptibility of 124 Xanthomonas maltophilia (Stenotrophomonas maltophilia) isolates: comparison of the agar dilution method with the E-test and two agar diffusion methods.
    Arpi M; Victor MA; Mortensen I; Gottschau A; Bruun B
    APMIS; 1996 Feb; 104(2):108-14. PubMed ID: 8619912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of beta-lactamase inhibitors in combination with new beta-lactam antibiotics against resistant gram-negative organisms.
    Bolivar R; Weaver SS; Bodey GP
    Diagn Microbiol Infect Dis; 1984 Jun; 2(3):255-60. PubMed ID: 6086213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of beta-lactamase inhibitors on minimum inhibitory concentration of ampicillin and amoxicillin for Staphylococcus aureus strains.
    Paniagua GL; Monroy E; García O; Vaca S
    Rev Latinoam Microbiol; 1998; 40(3-4):128-34. PubMed ID: 10932741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stenotrophomonas (Xanthomonas) maltophilia: in vitro susceptibility to selected antimicrobial drugs, single and combined, with and without defibrinated human blood.
    Traub WH; Leonhard B; Bauer D
    Chemotherapy; 1998; 44(5):293-304. PubMed ID: 9732143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of various antibiotic combinations using the E-Test method in multiresistant Pseudomonas aeruginosa strains.
    Kocazeybek B; Arabaci U; Erentürk S; Akdur H
    Chemotherapy; 2002 Mar; 48(1):31-5. PubMed ID: 11901254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro susceptibility of Nocardia asteroides to 21 beta-lactam antibiotics, in combination with three beta-lactamase inhibitors, and its relationship to the beta-lactamase content.
    Kitzis MD; Gutmann L; Acar JF
    J Antimicrob Chemother; 1985 Jan; 15(1):23-30. PubMed ID: 3882654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli to 12 beta-lactam agents and combinations with beta-lactamase inhibitors.
    Tajada P; Gomez-Graces JL; Alós JI; Balas D; Cogollos R
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1924-5. PubMed ID: 8843305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance of Xanthomonas maltophilia to antibiotics and the effect of beta-lactamase inhibitors.
    Neu HC; Saha G; Chin NX
    Diagn Microbiol Infect Dis; 1989; 12(3):283-5. PubMed ID: 2791491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
    Sader HS; Tosin I; Sejas L; Miranda E
    Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antibiotic susceptibilities of Xanthomonas maltophilia and their relation to clinical management.
    Smit WJ; Boquest AL; Geddes JE; Tosolini FA
    Pathology; 1994 Jul; 26(3):321-4. PubMed ID: 7991292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro susceptibility of 33 clinical case isolates of Xanthomonas maltophilia. Inconsistent correlation of agar dilution and of disk diffusion test results.
    Hohl P; Frei R; Aubry P
    Diagn Microbiol Infect Dis; 1991; 14(5):447-50. PubMed ID: 1797460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of 13 beta-lactam agents combined with BRL 42715 against beta-lactamase producing gram-negative bacteria compared to combinations with clavulanic acid, tazobactam and sulbactam.
    Piddock LJ; Jin YF; Turner HL
    J Antimicrob Chemother; 1993 Jan; 31(1):89-103. PubMed ID: 8383105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.